Biomarkers & Testing
Coeliac blood tests: when a result needs confirmation
Coeliac antibody results need clinical context. Learn why negative tests can miss disease, when biopsy helps, and what selected no-biopsy pathways mean.
Read the articleExplore the journal
Biomarkers & Testing
Understanding blood panels, biological age tests, and key health metrics to track your longevity journey.
Biomarkers & Testing
Alzheimer’s blood tests: when the result can help care
Alzheimer’s blood tests can support assessment of memory symptoms. Their accuracy depends on the assay, the setting and how uncertain results are handled.
Read the article
Biomarkers & Testing
Raised PSA results: how repeat testing and MRI help
A raised PSA result needs context. Explore repeat testing, MRI, biopsy, and the limits of screening evidence before discussing next steps with a clinician.
Read the article
Biomarkers & Testing
High-sensitivity troponin: what a low-level result means
High-sensitivity troponin can detect tiny signals from heart muscle, but it is not a home cardiac screen or a result to interpret without clinical context.
Read the article
Biomarkers & Testing
ApoB, LDL-C and residual risk: when lipid tests disagree
ApoB, LDL-C and non-HDL are not interchangeable. In metabolic states they can diverge, so prevention should match whole-person risk, not one marker.
Read the article
Biomarkers & Testing
Kidney biomarker trends, not single snapshots, explain risk
A single kidney result can mislead; what matters is how eGFR and urine albumin behave over repeated, clinically grounded measurements, not a one-off snapshot.
Read the article
Biomarkers & Testing
Cystatin C Tests: What This Kidney Marker Can Tell You
Cystatin C can make a kidney-function estimate clearer when creatinine is hard to interpret, but it is not a stand-alone measure of longevity.
Read the article
Biomarkers & Testing
IGF-1 Testing: Growth Signal, Not a Longevity Score
IGF-1 can help clinicians investigate growth-hormone disorders, but it is not a stand-alone score for ageing, cancer risk, or personal longevity.
Read the article
Biomarkers & Testing
DXA Scans: Useful Bone Signal, Not a Body-Age Verdict
DXA scans can clarify bone-density risk, but body-composition reports still need cautious interpretation, repeatable methods, and clinical context.
Read the article
Biomarkers & Testing
CAC Score Testing: Plaque Signal, Not a Heart Verdict
Coronary artery calcium scoring can sharpen heart-risk estimates, but a single number cannot tell you whether plaque is blocking flow or what to do next.
Read the articleFind a little clarity